Pharmaceuticals
Regulatory Science
Santhera proposes Dr Srishti Gupta for board ahead of May AGM
The Swiss rare-disease pharma is putting the former Idorsia CEO forward as an independent director at its 26 May annual general meeting.
The Swiss rare-disease pharma is putting the former Idorsia CEO forward as an independent director at its 26 May annual general meeting.